인쇄하기
취소

KDRA to move forward study on new biopharmaceuticals

Published: 2013-07-16 06:59:00
Updated: 2013-07-16 06:59:00
The Korea Drug Research Association (KDRA) will conduct a study on the feasibility of new biotech projects in seven sectors – low molecular weight drugs, natural products, biological drugs, antibodies, regenerative drugs, drug platform technologies and other chemical products, officials said Monday.

The KDRA said the feasibility study results will be made public by the Korea Evaluation Insti...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.